Regeneron flashes 'great advance' in the NEJM for that other cholesterol drug sitting at the FDA
Five patients on the treatment arm saw an influenza-like illness but no ... with doubts about the durability of BioMarin's hemophilia A gene therapy. http://dlvr.it/Rdzn4F
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.